Skip to content

Maxele Advisors, LLC: XLV position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Maxele Advisors, LLC on XLV, newest first. How the timeline and the estimate are built.

Maxele Advisors, LLC held 22,132 XLV shares at 2026-06-30 per its 13F-HR filed 2026-08-17.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 22,132 shares
    Change vs previous 13F -708 shares

    2.45% of the 13F portfolio, value $3,511,405.

    13F-HR 0002096567-26-000002 filed by Maxele Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2025-12-31
    13F 22,840 shares
    Change vs previous 13F -253 shares

    2.87% of the 13F portfolio, value $3,535,671.

    13F-HR 0002096567-26-000001 filed by Maxele Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-09-30
    13F 23,093 shares
    Change vs previous 13F -165 shares

    2.77% of the 13F portfolio, value $3,213,862.

    13F-HR 0002096567-25-000001 filed by Maxele Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-06-30
    13F 23,258 shares
    Change vs previous 13F -280 shares

    2.73% of the 13F portfolio, value $3,134,928.

    13F-HR 0002096567-25-000008 filed by Maxele Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-03-31
    13F 23,538 shares
    Change vs previous 13F -339 shares

    3.32% of the 13F portfolio, value $3,436,733.

    13F-HR 0002096567-25-000007 filed by Maxele Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2024-12-31
    13F 23,877 shares
    Change vs previous 13F not available

    3.13% of the 13F portfolio, value $3,284,826.

    13F-HR 0002096567-25-000006 filed by Maxele Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).